Recent advances in pre-clinical mouse models of COPD

Clinical Science

Volumn 126, Issue 4, 2014, Pages 253-265

  Vlahos, Ross ^a   Bozinovski, Steven ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Acute exacerbations of chronic obstructive pulmonary disease (aecopd); Chronic Obstructive Pulmonary Disease (COPD); Emphysema; Inflammation; Skeletal muscle wasting; Smoking

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTISENSE OLIGONUCLEOTIDE; AZ 11557272; CATHEPSIN K; CATHEPSIN L; CATHEPSIN S; CIGARETTE SMOKE; CORTICOSTEROID; GAMMA INTERFERON; GELATINASE A; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GSK 256066; INTERLEUKIN 6; LEUKOTRIENE B4; MATRIX METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPEPTIDE Y; NEUTROPHIL COLLAGENASE; PHOSPHODIESTERASE IV INHIBITOR; REACTIVE OXYGEN METABOLITE; ROFLUMILAST; TG 100 115; THEOPHYLLINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UK 500 001; UK 500001; UNCLASSIFIED DRUG;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIARRHEA; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; EMPHYSEMA; EXPERIMENTAL MODEL; GENE EXPRESSION; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG FUNCTION; MACROPHAGE; NAUSEA; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REVIEW; T LYMPHOCYTE; TOTAL LUNG CAPACITY;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS; INFLAMMATION; MICE; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84886649088     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130182     Document Type: Review

References (140)

1. Lopez, A. D. and Murray, C. C. (1998) The global burden of disease, 1990-2020. Nat. Med. 4, 1241-1243
2. Barnes, P. J., Shapiro, S. D. and Pauwels, R. A. (2003) Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur. Respir. J. 22, 672-688
3. Dennis, R. J., Maldonado, D., Norman, S., Baena, E. and Martinez, G. (1996) Woodsmoke exposure and risk for obstructive airways disease among women. Chest 109, 115-119
4. Pauwels, R. A., Buist, A. S., Calverley, P. M., Jenkins, C. R. and Hurd, S. S. (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 163, 1256-1276
5. Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V. and Cabral, H. J. (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 1005-1012
6. Rohde, G., Wiethege, A., Borg, I., Kauth, M., Bauer, T. T., Gillissen, A., Bufe, A. and Schultze-Werninghaus, G. (2003) Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58, 37-42
7. Sethi, S. (2004) Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon? Proc. Am. Thoracic Soc. 1, 109-114
8. Seemungal, T., Harper-Owen, R., Bhowmik, A., Moric, I., Sanderson, G., Message, S., Maccallum, P., Meade, T. W., Jeffries, D. J., Johnston, S. L. and Wedzicha, J. A. (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164, 1618-1623
9. Barnes, P. J. and Celli, B. R. (2009) Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 33, 1165-1185
10. Pauwels, R. A., Lofdahl, C. G., Laitinen, L. A., Schouten, J. P., Postma, D. S., Pride, N. B. and Ohlsson, S. V. (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N. Engl. J. Med. 340, 1948-1953
11. Stevenson, C. S. and Birrell, M. A. (2011) Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance. Pharmacol. Ther. 130, 93-105
12. Vlahos, R., Bozinovski, S., Gualano, R. C., Ernst, M. and Anderson, G. P. (2006) Modelling COPD in mice. Pulm. Pharmacol. Ther. 19, 12-17
13. Stevenson, C. S. and Belvisi, M. G. (2008) Preclinical animal models of asthma and chronic obstructive pulmonary disease. Expert Rev. Respir. Med. 2, 631-643
14. Churg, A., Cosio, M. and Wright, J. L. (2008) Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am. J. Physiol. Lung Cell. Mol. Physiol. 294, L612-L631
15. Wright, J. L., Cosio, M. and Churg, A. (2008) Animal models of chronic obstructive pulmonary disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L1-L15
16. Wright, J. L. and Churg, A. (2010) Animal models of cigarette smoke-induced chronic obstructive pulmonary disease. Expert Rev. Respir. Med. 4, 723-734
17. Goldklang, M. P., Marks, S. M. and D'Armiento, J. M. (2013) Second hand smoke and COPD: lessons from animal studies. Front. Physiol. 4, 30
18. Pesci, A., Balbi, B., Majori, M., Cacciani, G., Bertacco, S., Alciato, P. and Donner, C. F. (1998) Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur. Respir. J. 12, 380-386
19. Keatings, V. M., Collins, P. D., Scott, D. M. and Barnes, P. J. (1996) Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 153, 530-534
20. Retamales, I., Elliott, W. M., Meshi, B., Coxson, H. O., Pare, P. D., Sciurba, F. C., Rogers, R. M., Hayashi, S. and Hogg, J. C. (2001) Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am. J. Respir. Crit. Care Med. 164, 469-473
21. Di Stefano, A., Capelli, A., Lusuardi, M., Balbo, P., Vecchio, C., Maestrelli, P., Mapp, C. E., Fabbri, L. M., Donner, C. F. and Saetta, M. (1998) Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am. J. Respir. Crit. Care Med. 158, 1277-1285
22. Stanescu, D., Sanna, A., Veriter, C., Kostianev, S., Calcagni, P. G., Fabbri, L. M. and Maestrelli, P. (1996) Airways obstruction, chronic expectoration and rapid decline in FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 51, 267-271
23. Saetta, M., Di Stefano, A., Turato, G., Facchini, F. M., Corbino, L., Mapp, C. E., Maestrelli, P., Ciaccia, A. and Fabbri, L. M. (1998) CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 157, 822-826
24. Saetta, M., Baraldo, S., Turato, G., Beghe, B., Casoni, G. L., Bellettato, C. M., Rea, F., Zuin, R., Fabbri, L. M. and Papi, A. (2003) Increased proportion of CD8+ T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPD. Sarcoidosis Vasc. Diffuse Lung Dis. 20, 28-32
25. Zhao, M. Q., Stoler, M. H., Liu, A. N., Wei, B., Soguero, C., Hahn, Y. S. and Enelow, R. I. (2000) Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8+ T-cell recognition. J. Clin. Invest. 106, R49-58
26. Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O. and Pare, P. D. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 2645-2653
27. Shapiro, S. D. (2002) Proteinases in chronic obstructive pulmonary disease. Biochem. Soc. Trans. 30, 98-102
28. Parks, W. C. and Shapiro, S. D. (2001) Matrix metalloproteinases in lung biology. Respir. Res. 2, 10-19
29. Russell, R. E., Thorley, A., Culpitt, S. V., Dodd, S., Donnelly, L. E., Demattos, C., Fitzgerald, M. and Barnes, P. J. (2002) Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am. J. Physiol. Lung Cell. Mol. Physiol. 283, L867-L873
30. Finlay, G. A., O'Driscoll, L. R., Russell, K. J., D'Arcy, E. M., Masterson, J. B., Fitz Gerald, M. X. and O'Connor, C. M. (1997) Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am. J. Respir. Crit. Care Med. 156, 240-247
31. Ohnishi, K., Takagi, M., Kurokawa, Y., Satomi, S. and Konttinen, Y. T. (1998) Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab. Invest. 78, 1077-1087
32. Russell, R. E., Culpitt, S. V., DeMatos, C., Donnelly, L., Smith, M., Wiggins, J. and Barnes, P. J. (2002) Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell. Mol. Biol. 26, 602-609
33. Cawston, T., Carrere, S., Catterall, J., Duggleby, R., Elliott, S., Shingleton, B. and Rowan, A. (2001) Matrix metalloproteinases and TIMPs: properties and implications for the treatment of chronic obstructive pulmonary disease. Novartis Found. Symp. 234, 205-218
34. Beeh, K. M., Beier, J., Kornmann, O. and Buhl, R. (2003) Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respir. Med. 97, 634-639
35. Cataldo, D., Munaut, C., Noel, A., Frankenne, F., Bartsch, P., Foidart, J. M. and Louis, R. (2000) MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int. Arch. Allergy Immunol. 123, 259-267
36. Rahman, I. (2012) Pharmacological antioxidant strategies as therapeutic interventions for COPD. Biochim. Biophys. Acta 1822, 714-728
37. Vlahos, R., Stambas, J. and Selemidis, S. (2012) Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy. Trends Pharmacol. Sci. 33, 3-8
38. Vlahos, R. and Bozinovski, S. (2013) Glutathione peroxidase-1 as a novel therapeutic target for COPD. Redox Report 18, 142-149
39. Vlahos, R., Stambas, J., Bozinovski, S., Broughton, B. R., Drummond, G. R. and Selemidis, S. (2011) Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog. 7, e1001271
40. Dahl, M., Bowler, R. P., Juul, K., Crapo, J. D., Levy, S. and Nordestgaard, B. G. (2008) Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations. Am. J. Respir. Crit. Care Med. 178, 906-912
41. Rahman, I. and Adcock, I. M. (2006) Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J. 28, 219-242
42. Nowak, D., Antczak, A., Krol, M., Pietras, T., Shariati, B., Bialasiewicz, P., Jeczkowski, K. and Kula, P. (1996) Increased content of hydrogen peroxide in the expired breath of cigarette smokers. Eur. Respir. J. 9, 652-657
43. Mahadeva, R. and Shapiro, S. D. (2002) Chronic obstructive pulmonary disease · 3: Experimental animal models of pulmonary emphysema. Thorax 57, 908-914
44. Shapiro, S. D. (2000) Animal models for chronic obstructive pulmonary disease: age of klotho and marlboro mice. Am. J. Respir. Cell. Mol. Biol. 22, 4-7
45. Wright, J. L. and Churg, A. (2002) Animal models of cigarette smoke-induced COPD. Chest 122 (Suppl. 6), 301S-306S
46. Dawkins, P. A. and Stockley, R. A. (2001) Animal models of chronic obstructive pulmonary disease. Thorax 56, 972-977
47. Shapiro, S. D. (2000) Animal models for COPD. Chest 117 (Suppl. 1), 223S-227S
48. Churg, A., Wang, R. D., Tai, H., Wang, X., Xie, C., Dai, J., Shapiro, S. D. and Wright, J. L. (2003) Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-α release. Am. J. Respir. Crit. Care Med. 167, 1083-1089
49. Churg, A., Zay, K., Shay, S., Xie, C., Shapiro, S. D., Hendricks, R. and Wright, J. L. (2002) Acute cigarette smoke-induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice. Am. J. Respir. Cell. Mol. Biol. 27, 368-374
50. Churg, A., Wang, R. D., Tai, H., Wang, X., Xie, C. and Wright, J. L. (2004) Tumor necrosis factor-α drives 70% of cigarette smoke-induced emphysema in the mouse. Am. J. Respir. Crit. Care Med. 170, 492-498
51. Bozinovski, S., Vlahos, R., Zhang, Y., Lah, L. C., Seow, H. J., Mansell, A. and Anderson, G. P. (2011) Carbonylation caused by cigarette smoke extract is associated with defective macrophage immunity. Am. J. Respir. Cell. Mol. Biol. 45, 229-236
52. Vlahos, R., Bozinovski, S., Jones, J. E., Powell, J., Gras, J., Lilja, A., Hansen, M. J., Gualano, R. C., Irving, L. and Anderson, G. P. (2006) Differential protease, innate immunity, and NFκB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L931-L945
53. Duong, C., Seow, H. J., Bozinovski, S., Crack, P. J., Anderson, G. P. and Vlahos, R. (2010) Glutathione peroxidase-1 protects against cigarette smoke-induced lung inflammation in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 299, L425-L433
54. Beckett, E. L., Stevens, R. L., Jarnicki, A. G., Kim, R. Y., Hanish, I., Hansbro, N. G., Deane, A., Keely, S., Horvat, J. C., Yang, M. et al. (2013) A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for masT-cell tryptase in pathogenesis. J. Allergy Clin. Immunol. 131, 752-762
55. Stevenson, C. S., Docx, C., Webster, R., Battram, C., Hynx, D., Giddings, J., Cooper, P. R., Chakravarty, P., Rahman, I., Marwick, J. A. et al. (2007) Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L1183-L1193
56. Rastrick, J. M., Stevenson, C. S., Eltom, S., Grace, M., Davies, M., Kilty, I., Evans, S. M., Pasparakis, M., Catley, M. C., Lawrence, T. et al. (2013) Cigarette smoke induced airway inflammation is independent of NF-κB signalling. PLoS ONE 8, e54128
57. Eltom, S., Stevenson, C. S., Rastrick, J., Dale, N., Raemdonck, K., Wong, S., Catley, M. C., Belvisi, M. G. and Birrell, M. A. (2011) P2×7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke. PLoS ONE 6, e24097
58. Wan, W. Y., Morris, A., Kinnear, G., Pearce, W., Mok, J., Wyss, D. and Stevenson, C. S. (2010) Pharmacological characterisation of anti-inflammatory compounds in acute and chronic mouse models of cigarette smoke-induced inflammation. Respir. Res. 11, 126
59. Marwick, J. A., Edirisinghe, I., Arunachalam, G., Stevenson, C. S., Macnee, W., Kirkham, P. A. and Rahman, I. (2010) Cigarette smoke regulates VEGFR2-mediated survival signaling in rat lungs. J. Inflamm. 7, 11
60. Marwick, J. A., Caramori, G., Stevenson, C. S., Casolari, P., Jazrawi, E., Barnes, P. J., Ito, K., Adcock, I. M., Kirkham, P. A. and Papi, A. (2009) Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. Am. J. Respir. Crit. Care Med. 179, 542-548
61. Morris, A., Kinnear, G., Wan, W. Y., Wyss, D., Bahra, P. and Stevenson, C. S. (2008) Comparison of cigarette smoke-induced acute inflammation in multiple strains of mice and the effect of a matrix metalloproteinase inhibitor on these responses. J. Pharmacol. Exp. Ther. 327, 851-862
62. Churg, A., Marshall, C. V., Sin, D. D., Bolton, S., Zhou, S., Thain, K., Cadogan, E. B., Maltby, J., Soars, M. G., Mallinder, P. R. and Wright, J. L. (2012) Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 185, 34-43
63. Churg, A., Zhou, S. and Wright, J. L. (2012) Matrix metalloproteinases in COPD. Eur. Respir. J. 39, 197-209
64. Yao, H., Chung, S., Hwang, J. W., Rajendrasozhan, S., Sundar, I. K., Dean, D. A., McBurney, M. W., Guarente, L., Gu, W., Ronty, M. et al. (2012) SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J. Clin. Invest. 122, 2032-2045
65. Yao, H., Arunachalam, G., Hwang, J. W., Chung, S., Sundar, I. K., Kinnula, V. L., Crapo, J. D. and Rahman, I. (2010) Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM. Proc. Natl. Acad. Sci. U.S.A. 107, 15571-15576
66. Brusselle, G. G., Bracke, K. R., Maes, T., D'Hulst A, I., Moerloose, K. B., Joos, G. F. and Pauwels, R. A. (2006) Murine models of COPD. Pulm. Pharmacol. Ther. 19, 155-165
67. Bracke, K. R., Verhamme, F. M., Seys, L. J., Bantsimba-Malanda, C., Cunoosamy, D. M., Herbst, R., Hammad, H., Lambrecht, B. N., Joos, G. F. and Brusselle, G. G. (2013) Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and COPD. Am. J. Respir. Crit. Care Med. 188, 343-355
68. Hautamaki, R. D., Kobayashi, D. K., Senior, R. M. and Shapiro, S. D. (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277, 2002-2004
69. Morris, D. G., Huang, X., Kaminski, N., Wang, Y., Shapiro, S. D., Dolganov, G., Glick, A. and Sheppard, D. (2003) Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysema. Nature 422, 169-173
70. Guerassimov, A., Hoshino, Y., Takubo, Y., Turcotte, A., Yamamoto, M., Ghezzo, H., Triantafillopoulos, A., Whittaker, K., Hoidal, J. R. and Cosio, M. G. (2004) The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am. J. Respir. Crit. Care Med. 170, 974-980
71. Cavarra, E., Bartalesi, B., Lucattelli, M., Fineschi, S., Lunghi, B., Gambelli, F., Ortiz, L. A., Martorana, P. A. and Lungarella, G. (2001) Effects of cigarette smoke in mice with different levels of α-proteinase inhibitor and sensitivity to oxidants. Am. J. Respir. Crit. Care Med. 164, 886-890
72. Shapiro, S. D., Demeo, D. L. and Silverman, E. K. (2004) Smoke and mirrors: mouse models as a reflection of human chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 170, 929-931
73. Ernst, M., Inglese, M., Scholz, G. M., Harder, K. W., Clay, F. J., Bozinovski, S., Waring, P., Darwiche, R., Kay, T., Sly, P. et al. (2002) Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response. J. Exp. Med. 196, 589-604
74. Ruwanpura, S. M., McLeod, L., Miller, A., Jones, J., Bozinovski, S., Vlahos, R., Ernst, M., Armes, J., Bardin, P. G., Anderson, G. P. and Jenkins, B. J. (2011) Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice. Am. J. Respir. Cell. Mol. Biol. 45, 720-730
75. Rinaldi, M., Maes, K., De Vleeschauwer, S., Thomas, D., Verbeken, E. K., Decramer, M., Janssens, W. and Gayan-Ramirez, G. N. (2012) Long-term nose-only cigarette smoke exposure induces emphysema and mild skeletal muscle dysfunction in mice. Dis. Model Mech. 5, 333-341
76. Jobse, B. N., Rhem, R. G., Wang, I. Q., Counter, W. B., Stampfli, M. R. and Labiris, N. R. (2013) Detection of lung dysfunction using ventilation and perfusion SPECT in a mouse model of chronic cigarette smoke exposure. J. Nucl. Med. 54, 616-623
77. Seemungal, T. A., Donaldson, G. C., Paul, E. A., Bestall, J. C., Jeffries, D. J. and Wedzicha, J. A. (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 157, 1418-1422
78. Crooks, S. W., Bayley, D. L., Hill, S. L. and Stockley, R. A. (2000) Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur. Respir. J. 15, 274-280
79. Aaron, S. D., Angel, J. B., Lunau, M., Wright, K., Fex, C., Le Saux, N. and Dales, R. E. (2001) Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163, 349-355
80. Bhowmik, A., Seemungal, T. A., Sapsford, R. J. and Wedzicha, J. A. (2000) Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 55, 114-120
81. Gompertz, S., Bayley, D. L., Hill, S. L. and Stockley, R. A. (2001) Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax 56, 36-41
82. Caramori, G., Romagnoli, M., Casolari, P., Bellettato, C., Casoni, G., Boschetto, P., Chung, F. K., Barnes, P. J., Adcock, I. M., Ciaccia, A. et al. (2003) Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax 58, 348-351
83. Sethi, S. (2000) Infectious etiology of acute exacerbations of chronic bronchitis. Chest 117 (Suppl 2), 380S-385S
84. Seemungal, T. A., Harper-Owen, R., Bhowmik, A., Jeffries, D. J. and Wedzicha, J. A. (2000) Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur. Respir. J. 16, 677-683
85. Robbins, C. S., Dawe, D. E., Goncharova, S. I., Pouladi, M. A., Drannik, A. G., Swirski, F. K., Cox, G. and Stampfli, M. R. (2004) Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am. J. Respir. Cell. Mol. Biol. 30, 202-211
86. Gualano, R. C., Hansen, M. J., Vlahos, R., Jones, J. E., Park-Jones, R. A., Deliyannis, G., Turner, S. J., Duca, K. A. and Anderson, G. P. (2008) Cigarette smoke worsens lung inflammation and impairs resolution of influenza infection in mice. Respir. Res. 9, 53
87. Bauer, C. M., Zavitz, C. C., Botelho, F. M., Lambert, K. N., Brown, E. G., Mossman, K. L., Taylor, J. D. and Stampfli, M. R. (2010) Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection. PLoS ONE 5, e13251
88. Robbins, C. S., Bauer, C. M., Vujicic, N., Gaschler, G. J., Lichty, B. D., Brown, E. G. and Stampfli, M. R. (2006) Cigarette smoke impacts immune inflammatory responses to influenza in mice. Am. J. Respir. Crit. Care Med. 174, 1342-1351
89. Kang, M. J., Lee, C. G., Lee, J. Y., Dela Cruz, C. S., Chen, Z. J., Enelow, R. and Elias, J. A. (2008) Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J. Clin. Invest. 118, 2771-2784
90. Kimura, G., Ueda, K., Eto, S., Watanabe, Y., Masuko, T., Kusama, T., Barnes, P. J., Ito, K. and Kizawa, Y. (2013) Toll-like receptor 3 stimulation causes corticosteroid-refractory airway neutrophilia and hyperresponsiveness in mice. Chest 144, 99-105
91. Sin, D. D. and Paul Man, S. F. (2005) Chronic Obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc. Am. Thoracic Soc. 2, 8-11
92. Chatila, W., Thomashow, B. M., Minai, O. A., Criner, G. J. and Make, B. (2008) Comorbidities in chronic obstructive pulmonary disease. Proc. Am. Thoracic Soc. 5, 549-555
93. Berger, J. S., Sanborn, T. A., Sherman, W. and Brown, D. L. (2004) Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention. Am. J. Cardiol. 94, 649-651
94. Curkendall, S. M., DeLuise, C., Jones, J. K., Lanes, S., Stang, M. R., Goehring, Jr, E. and She, D. (2006) Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann. Epidemiol. 16, 63-70
95. Schols, A. M., Slangen, J., Volovics, L. and Wouters, E. F. (1998) Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 157, 1791-1797
96. Gosker, H. R., Engelen, M. P., van Mameren, H., van Dijk, P. J., van der Vusse, G. J., Wouters, E. F. and Schols, A. M. (2002) Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 76, 113-119
97. Allaire, J., Maltais, F., Doyon, J. F., Noel, M., LeBlanc, P., Carrier, G., Simard, C. and Jobin, J. (2004) Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax 59, 673-678
98. Maltais, F., LeBlanc, P., Whittom, F., Simard, C., Marquis, K., Belanger, M., Breton, M. J. and Jobin, J. (2000) Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 55, 848-853
99. Schols, A. M., Buurman, W. A., Staal van den Brekel, A. J., Dentener, M. A. and Wouters, E. F. (1996) Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 51, 819-824
100. Yende, S., Waterer, G. W., Tolley, E. A., Newman, A. B., Bauer, D. C., Taaffe, D. R., Jensen, R., Crapo, R., Rubin, S., Nevitt, M. et al. (2006) Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 61, 10-16
101. Pinto-Plata, V. M., Mullerova, H., Toso, J. F., Feudjo-Tepie, M., Soriano, J. B., Vessey, R. S. and Celli, B. R. (2006) C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 61, 23-28
102. Broekhuizen, R., Wouters, E. F., Creutzberg, E. C. and Schols, A. M. (2006) Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61, 17-22
103. Gan, W. Q., Man, S. F., Senthilselvan, A. and Sin, D. D. (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59, 574-580
104. Barreiro, E., Peinado, V. I., Galdiz, J. B., Ferrer, E., Marin-Corral, J., Sanchez, F., Gea, J. and Barbera, J. A. (2012) Cigarette smoke-induced oxidative stress: a role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am. J. Respir. Crit. Care Med. 182, 477-488
105. Chen, H., Hansen, M. J., Jones, J. E., Vlahos, R., Bozinovski, S., Anderson, G. P. and Morris, M. J. (2006) Cigarette smoke exposure reprograms the hypothalamic neuropeptide y axis to promote weight loss. Am. J. Respir. Crit. Care Med. 173, 1248-1254
106. Chen, H., Vlahos, R., Bozinovski, S., Jones, J., Anderson, G. P. and Morris, M. J. (2005) Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice. Neuropsychopharmacology 30, 713-719
107. Hansen, M. J., Langenbach, S., Dousha, L., Ferdinando, O., Allan, D., Kosack, L., Seow, H. J., Chan, J. S., Jones, J. E. and Anderson, G. P. (2009) The prolonged effects of cigarette smoke exposure on lung inflammation and skeletal muscle wasting in mice. Am. J. Respir. Crit. Care Med. 179, A2934
108. Hansen, M. J., Gualano, R. C., Bozinovski, S., Vlahos, R. and Anderson, G. P. (2006) Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease). Pharmacol. Ther. 109, 162-172
109. Chen, H., Hansen, M. J., Jones, J. E., Vlahos, R., Anderson, G. P. and Morris, M. J. (2007) Detrimental metabolic effects of combining long-term cigarette smoke exposure and high-fat diet in mice. Am. J. Physiol. Endocrinol. Metab. 293, E1564-E1571
110. Hansen, M. J., Chen, H., Jones, J. E., Langenbach, S. Y., Gualano, R. C., Vlahos, R., Morris, M. J. and Anderson, G. P. (2008) Cigarette smoke-induced lung inflammation and skeletal muscle wasting are not altered by a high-fat diet in mice. Am. J. Respir. Crit. Care Med. 177, A867
111. Hansen, M. J., Chen, H., Gualano, R. C., Jones, J. E., Vlahos, R., Morris, M. J. and Anderson, G. P. (2007) The balance of atrogin-1 and insulin-like growth factor-1 mRNA expression may contribute to wasting after long-term cigarette smoke exposure in mice. Am. J. Respir. Crit. Care Med. 175, A649
112. Gosker, H. R., Langen, R. C., Bracke, K. R., Joos, G. F., Brusselle, G. G., Steele, C., Ward, K. A., Wouters, E. F. and Schols, A. M. (2009) Extrapulmonary manifestations of chronic obstructive pulmonary disease in a mouse model of chronic cigarette smoke exposure. Am. J. Respir. Cell. Mol. Biol. 40, 710-716
113. Tang, K., Wagner, P. D. and Breen, E. C. (2010) TNF-α-mediated reduction in PGC-1α may impair skeletal muscle function after cigarette smoke exposure. J. Cell. Physiol. 222, 320-327
114. Basic, V. T., Tadele, E., Elmabsout, A. A., Yao, H., Rahman, I., Sirsjo, A. and Abdel-Halim, S. M. (2012) Exposure to cigarette smoke induces overexpression of von Hippel-Lindau tumor suppressor in mouse skeletal muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 303, L519-L527
115. Hu, N., Han, X., Lane, E. K., Gao, F., Zhang, Y. and Ren, J. (2013) Cardiac-specific overexpression of metallothionein rescues against cigarette smoking exposure-induced myocardial contractile and mitochondrial damage. PLoS ONE 8, e57151
116. Sussan, T. E., Rangasamy, T., Blake, D. J., Malhotra, D., El-Haddad, H., Bedja, D., Yates, M. S., Kombairaju, P., Yamamoto, M., Liby, K. T. et al. (2009) Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc. Natl. Acad. Sci. U.S.A. 106, 250-255
117. Talukder, M. A., Johnson, W. M., Varadharaj, S., Lian, J., Kearns, P. N., El-Mahdy, M. A., Liu, X. and Zweier, J. L. (2011) Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am. J. Physiol. Heart Circ. Physiol. 300, H388-H396
118. Podowski, M., Calvi, C., Metzger, S., Misono, K., Poonyagariyagorn, H., Lopez-Mercado, A., Ku, T., Lauer, T., McGrath-Morrow, S., Berger, A. et al. (2012) Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice. J. Clin. Invest. 122, 229-240
119. Wright, J. L., Zhou, S., Preobrazhenska, O., Marshall, C., Sin, D. D., Laher, I., Golbidi, S. and Churg, A. M. (2011) Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling. Am. J. Respir. Crit. Care Med. 183, 50-58
120. Lee, J. H., Lee, D. S., Kim, E. K., Choe, K. H., Oh, Y. M., Shim, T. S., Kim, S. E., Lee, Y. S. and Lee, S. D. (2005) Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am. J. Respir. Crit. Care Med. 172, 987-993
121. Barnes, P. J. (2013) New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat. Rev. Drug Discovery 12, 543-559
122. Vlahos, R., Bozinovski, S., Hamilton, J. A. and Anderson, G. P. (2006) Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). Pharmacol. Ther. 112, 106-115
123. Vlahos, R., Bozinovski, S., Chan, S. P., Ivanov, S., Linden, A., Hamilton, J. A. and Anderson, G. P. (2010) Neutralizing granulocyte/macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammation. Am. J. Respir. Crit. Care Med. 182, 34-40
124. Shapiro, S. D., Goldstein, N. M., Houghton, A. M., Kobayashi, D. K., Kelly, D. and Belaaouaj, A. (2003) Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am. J. Pathol. 163, 2329-2335
125. Stevens, T., Ekholm, K., Gr̈anse, M., Lindahl, M., Kozma, V., Jungar, C., Ottosson, T., Falk-Hsupo/supakansson, H., Churg, A., Wright, J. L. et al. (2011) AZD9668: pharmacological characterization of a novel oral inhibitor of neutrophil elastase. J. Pharmacol. Exp. Ther. 339, 313-320
126. Kuna, P., Jenkins, M., O'Brien, C. D. and Fahy, W. A. (2012) AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD. Respir. Med. 106, 531-539
127. Churg, A., Wang, R., Wang, X., Onnervik, P. O., Thim, K. and Wright, J. L. (2007) Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs. Thorax 62, 706-713
128. Vestbo, J., Tan, L., Atkinson, G., Ward, J. and Uk, G. S. T. (2009) A controlled trial of 6-weeks' treatment with a novel inhaled phosphodiesterase type-4 inhibitor in COPD. Eur. Respir. J. 33, 1039-1044
129. Nials, A. T., Tralau-Stewart, C. J., Gascoigne, M. H., Ball, D. I., Ranshaw, L. E. and Knowles, R. G. (2011) In vivo characterization of GSK256066, a high-affinity inhaled phosphodiesterase 4 inhibitor. J. Pharmacol. Exp. Ther. 337, 137-144
130. Watz, H., Mistry, S. J. and Lazaar, A. L. (2013) Safety and tolerability of the inhaled phosphodiesterase 4 inhibitor GSK256066 in moderate COPD. Pulm. Pharmacol. Ther. 26, 588-595
131. Fortin, M., D'Anjou, H., Higgins, M. E., Gougeon, J., Aube, P., Moktefi, K., Mouissi, S., Seguin, S., Seguin, R., Renzi, P. M. et al. (2009) A multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice. Respir. Res. 10, 39
132. Medicherla, S., Fitzgerald, M. F., Spicer, D., Woodman, P., Ma, J. Y., Kapoun, A. M., Chakravarty, S., Dugar, S., Protter, A. A. and Higgins, L. S. (2008) p38α-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation. J. Pharmacol. Exp. Ther. 324, 921-929
133. Ito, K., Ito, M., Elliott, W. M., Cosio, B., Caramori, G., Kon, O. M., Barczyk, A., Hayashi, S., Adcock, I. M., Hogg, J. C. and Barnes, P. J. (2005) Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N. Engl. J. Med. 352, 1967-1976
134. Marwick, J. A., Kirkham, P. A., Stevenson, C. S., Danahay, H., Giddings, J., Butler, K., Donaldson, K., Macnee, W. and Rahman, I. (2004) Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am. J. Respir. Cell. Mol. Biol. 31, 633-642
135. Fox, J. C., Spicer, D., Ito, K., Barnes, P. J. and Fitzgerald, M. F. (2007) Oral or inhaled corticosteroid combination therapy with low dose theophylline reverses corticosteroid insensitivity in a smoking mouse model. Am. J. Respir. Crit. Care Med. 175, A637
136. Fox, J. C. and Fitzgerald, M. F. (2009) The role of animal models in the pharmacological evaluation of emerging antiinflammatory agents for the treatment of COPD. Curr. Opin. Pharmacol. 9, 231-242
137. Malhotra, D., Thimmulappa, R. K., Mercado, N., Ito, K., Kombairaju, P., Kumar, S., Ma, J., Feller-Kopman, D., Wise, R., Barnes, P. and Biswal, S. (2011) Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients. J. Clin. Invest. 121, 4289-4302
138. Geraghty, P., Hardigan, A. A., Wallace, A. M., Mirochnitchenko, O., Thankachen, J., Arellanos, L., Thompson, V., D'Armiento, J. M. and Foronjy, R. R. (2013) The GPx1-PTP1B-PP2A axis: a key determinant of airway inflammation and alveolar destruction. Am. J. Respir. Cell. Mol. Biol., doi:10.1165/ rcmb.2013-00260C
139. Rangasamy, T., Cho, C. Y., Thimmulappa, R. K., Zhen, L., Srisuma, S. S., Kensler, T. W., Yamamoto, M., Petrache, I., Tuder, R. M. and Biswal, S. (2004) Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 114, 1248-1259
140. Stevenson, C. S., Sridhar, S. and Phillips, J. E. (2013) Predicting drug efficacy using integrative models for chronic respiratory diseases. Inflamm. Allergy Drug Targets 12, 124-131